Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer-Reference-Cited by-同舟云学术

Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer

Published:2022-02-23 Issue:1 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Patriquin Glenn¹²^ORCID,LeBlanc Jason J.¹²³⁴^ORCID,Williams Catherine⁵,Hatchette Todd F.¹²³⁴,Ross John⁶,Barrett Lisa³⁴,Davidson Ross¹²³⁴

Affiliation:

1. Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada

2. Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

3. Department of Medicine (Infectious Diseases), Dalhousie University, Halifax, Nova Scotia, Canada

4. Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

5. Department of Family Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

6. Praxes Medical Group, Halifax, Nova Scotia, Canada

Abstract

Nasal swabbing for SARS-CoV-2 (COVID-19) comes with many benefits but is slightly less sensitive than traditional nasopharyngeal swabbing; however, confirmatory lab-based testing could be performed directly from the residual buffer from either sample type.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02455-21

Reference43 articles.

1. Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories

2. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection

3. Generation of False-Positive SARS-CoV-2 Antigen Results with Testing Conditions outside Manufacturer Recommendations: A Scientific Approach to Pandemic Misinformation

4. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres

5. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Performance of the BD Respiratory Viral Panel for BD MAX™ System in Detecting SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus;Diagnostic Microbiology and Infectious Disease;2024-11

2. Taqman PACMAN: a simple molecular approach for positive rapid antigen test confirmation during periods of low prevalence;Microbiology Spectrum;2024-05-02

3. Clinical evaluation of a new COVID-19 antigen rapid test kit for detection of SARS-CoV-2;Diagnostic Microbiology and Infectious Disease;2024-02

4. Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test;Microbiology Spectrum;2023-12-12

5. Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2;Clinical Microbiology and Infection;2023-07